Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Denver | 340 Studies

Clinical Trials Breast CancerDenver

Breast Cancer Clinical Trials in Denver

Find 340 clinical trials for breast cancer near Denver, Colorado. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Denver

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 340 trials

CompletedA Phase III Trial For Patients With Metastatic Breast CancerThis is a phase III randomized study between the docetaxel/gemcitabine and docetaxel/ capecitabine doublets, with crossover to the alternate agent.NCT00191152·Glendale, Arizona and 64 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingShorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerThis phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple…NCT05929768·Birmingham, Alabama and 962 others

Active not recruitingA Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)This is a Phase III, randomized, open-label, 3-arm, multicenter, international study assessing the efficacy and safety of Dato-DXd with or without durvalumab compared with ICT in…NCT05629585·Gilbert, Arizona and 275 others

Active not recruitingDigital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast CancerThis randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer.NCT03233191·Birmingham, Alabama and 148 others

CompletedA Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, to assess PK and…NCT03752398·San Diego, California and 17 others

TerminatedStudy of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsONCR-177-101 is a phase 1, open-label, multi-center, dose escalation and expansion study of ONCR-177, an oncolytic Herpes Simplex Virus for intratumoral injection, alone and in…NCT04348916·Duarte, California and 10 others

RecruitingPhase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsThis is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects…NCT05232916·Mobile, Alabama and 178 others

CompletedE7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast CancerThe purpose of this study is to compare Overall Survival (OS), Progression Free Survival (PFS), objective tumor response rate, duration of response, and safety in patients treated…NCT00388726·Birmingham, Alabama and 136 others

Active not recruitingP-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsA Phase 1, open label, dose escalation and expanded cohort study of P-MUC1C-ALLO1 in adult subjects with advanced or metastatic epithelial derived solid tumors, including but not…NCT05239143·Irvine, California and 13 others

WithdrawnS0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells.NCT00217659·Los Angeles, California and 56 others

TerminatedEvaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid TumorsThe objective of this study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of BL-M17D1 in patients with HER2-Expressing or HER2-Mutant Advanced or Metastatic…NCT06714617·Denver, Colorado and 8 others

Active not recruitingHormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)This randomized phase III trial studies the best individual therapy for women who have node-negative, estrogen-receptor positive breast cancer by using a special test (Oncotype…NCT00310180·Anniston, Alabama and 1221 others

Active not recruitingStudy of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasThis is a Phase 1/2a open-label, multicenter, dose escalation and dose expansion trial in which IMT-009 will be administered by the intravenous (IV) route to participants with…NCT05565417·Tucson, Arizona and 8 others

CompletedReducing Breast Cancer Recurrence With Weight LossThe purpose of the ENERGY trial is to explore whether two different programs that are focused on weight management, through increased exercise and a healthy diet, are feasible…NCT01112839·Birmingham, Alabama and 3 others

Active not recruitingExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticThis randomized phase III trial studies exemestane and entinostat to see how well they work compared to exemestane alone in treating patients with hormone receptor-positive breast…NCT02115282·Birmingham, Alabama and 652 others

Active not recruitingDoxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerThis randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, and paclitaxel to see how well they work with or without bevacizumab in treating patients with…NCT00433511·Anniston, Alabama and 841 others

Active not recruitingA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.NCT05787587·Phoenix, Arizona and 26 others

RecruitingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsThe goal of the Monotherapy Dose Escalation phase (Part 1) of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity to…NCT06586957·Little Rock, Arkansas and 18 others

RecruitingA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatment of HR-positive…NCT07062965·Chandler, Arizona and 201 others

Active not recruitingSafety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With ChemotherapyThis study is a Phase II, multi-site, randomized, open-label clinical study to evaluate the safety, efficacy, and pharmacokinetics (PK) of BNT327 at two dose levels in combination…NCT06449222·Beverly Hills, California and 30 others

PreviousPage 7 of 17Next

Other Conditions in Denver

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma